vs

Side-by-side financial comparison of agilon health, inc. (AGL) and J.B. Hunt (JBHT). Click either name above to swap in a different company.

J.B. Hunt is the larger business by last-quarter revenue ($3.1B vs $1.6B, roughly 2.0× agilon health, inc.). J.B. Hunt runs the higher net margin — 5.8% vs -12.0%, a 17.9% gap on every dollar of revenue. On growth, agilon health, inc. posted the faster year-over-year revenue change (3.1% vs -1.6%). J.B. Hunt produced more free cash flow last quarter ($251.3M vs $-23.5M). Over the past eight quarters, J.B. Hunt's revenue compounded faster (2.6% CAGR vs -1.1%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

J.B. Hunt Transport Services, Inc. is an American transportation and logistics company based in Lowell, Arkansas. It was founded by Johnnie Bryan Hunt and Johnelle Hunt in Arkansas on August 10, 1961. By 1983, J.B. Hunt had grown into the 80th largest trucking firm in the US, with $623.47 million in revenue. At that time J.B. Hunt operated 550 tractors, 1,049 trailers, and had roughly 1,050 employees. J.B.

AGL vs JBHT — Head-to-Head

Bigger by revenue
JBHT
JBHT
2.0× larger
JBHT
$3.1B
$1.6B
AGL
Growing faster (revenue YoY)
AGL
AGL
+4.7% gap
AGL
3.1%
-1.6%
JBHT
Higher net margin
JBHT
JBHT
17.9% more per $
JBHT
5.8%
-12.0%
AGL
More free cash flow
JBHT
JBHT
$274.8M more FCF
JBHT
$251.3M
$-23.5M
AGL
Faster 2-yr revenue CAGR
JBHT
JBHT
Annualised
JBHT
2.6%
-1.1%
AGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGL
AGL
JBHT
JBHT
Revenue
$1.6B
$3.1B
Net Profit
$-188.9M
$181.1M
Gross Margin
Operating Margin
-12.3%
8.0%
Net Margin
-12.0%
5.8%
Revenue YoY
3.1%
-1.6%
Net Profit YoY
-78.5%
16.5%
EPS (diluted)
$1.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
JBHT
JBHT
Q4 25
$1.6B
$3.1B
Q3 25
$1.4B
$3.1B
Q2 25
$1.4B
$2.9B
Q1 25
$1.5B
$2.9B
Q4 24
$1.5B
$3.1B
Q3 24
$1.5B
$3.1B
Q2 24
$1.5B
$2.9B
Q1 24
$1.6B
$2.9B
Net Profit
AGL
AGL
JBHT
JBHT
Q4 25
$-188.9M
$181.1M
Q3 25
$-110.2M
$170.8M
Q2 25
$-104.4M
$128.6M
Q1 25
$12.1M
$117.7M
Q4 24
$-105.8M
$155.5M
Q3 24
$-117.6M
$152.1M
Q2 24
$-30.7M
$135.9M
Q1 24
$-6.1M
$127.5M
Operating Margin
AGL
AGL
JBHT
JBHT
Q4 25
-12.3%
8.0%
Q3 25
-9.1%
7.9%
Q2 25
-8.3%
6.7%
Q1 25
-1.4%
6.1%
Q4 24
-7.1%
6.6%
Q3 24
-9.2%
7.3%
Q2 24
-2.9%
7.0%
Q1 24
-0.4%
6.6%
Net Margin
AGL
AGL
JBHT
JBHT
Q4 25
-12.0%
5.8%
Q3 25
-7.7%
5.6%
Q2 25
-7.5%
4.4%
Q1 25
0.8%
4.0%
Q4 24
-6.9%
4.9%
Q3 24
-8.1%
5.0%
Q2 24
-2.1%
4.6%
Q1 24
-0.4%
4.3%
EPS (diluted)
AGL
AGL
JBHT
JBHT
Q4 25
$1.88
Q3 25
$1.76
Q2 25
$1.31
Q1 25
$1.17
Q4 24
$1.53
Q3 24
$1.49
Q2 24
$1.32
Q1 24
$1.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
JBHT
JBHT
Cash + ST InvestmentsLiquidity on hand
$173.7M
$17.3M
Total DebtLower is stronger
$35.0M
Stockholders' EquityBook value
$126.7M
$3.6B
Total Assets
$1.3B
$7.9B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
JBHT
JBHT
Q4 25
$173.7M
$17.3M
Q3 25
$171.7M
$52.3M
Q2 25
$171.4M
$50.9M
Q1 25
$136.9M
$43.4M
Q4 24
$188.2M
$47.0M
Q3 24
$148.2M
$120.0M
Q2 24
$109.5M
$53.5M
Q1 24
$111.7M
$64.2M
Total Debt
AGL
AGL
JBHT
JBHT
Q4 25
$35.0M
Q3 25
Q2 25
Q1 25
Q4 24
$977.7M
Q3 24
$1.0B
Q2 24
$1.5B
Q1 24
$1.4B
Stockholders' Equity
AGL
AGL
JBHT
JBHT
Q4 25
$126.7M
$3.6B
Q3 25
$306.1M
$3.6B
Q2 25
$408.9M
$3.7B
Q1 25
$500.3M
$3.9B
Q4 24
$471.0M
$4.0B
Q3 24
$574.9M
$4.0B
Q2 24
$676.6M
$4.1B
Q1 24
$689.3M
$4.2B
Total Assets
AGL
AGL
JBHT
JBHT
Q4 25
$1.3B
$7.9B
Q3 25
$1.6B
$8.1B
Q2 25
$1.7B
$8.2B
Q1 25
$1.9B
$8.3B
Q4 24
$1.7B
$8.3B
Q3 24
$2.1B
$8.3B
Q2 24
$2.2B
$8.4B
Q1 24
$2.3B
$8.4B
Debt / Equity
AGL
AGL
JBHT
JBHT
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
0.24×
Q3 24
0.26×
Q2 24
0.36×
Q1 24
0.33×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
JBHT
JBHT
Operating Cash FlowLast quarter
$-20.5M
$385.6M
Free Cash FlowOCF − Capex
$-23.5M
$251.3M
FCF MarginFCF / Revenue
-1.5%
8.1%
Capex IntensityCapex / Revenue
0.2%
4.3%
Cash ConversionOCF / Net Profit
2.13×
TTM Free Cash FlowTrailing 4 quarters
$-119.0M
$947.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
JBHT
JBHT
Q4 25
$-20.5M
$385.6M
Q3 25
$-18.2M
$486.4M
Q2 25
$-35.1M
$402.1M
Q1 25
$-32.0M
$404.2M
Q4 24
$16.4M
$317.6M
Q3 24
$-7.7M
$338.5M
Q2 24
$-18.7M
$360.6M
Q1 24
$-47.8M
$466.5M
Free Cash Flow
AGL
AGL
JBHT
JBHT
Q4 25
$-23.5M
$251.3M
Q3 25
$-21.3M
$352.4M
Q2 25
$-38.3M
$185.6M
Q1 25
$-35.8M
$158.4M
Q4 24
$13.2M
$93.3M
Q3 24
$-11.2M
$163.1M
Q2 24
$-22.0M
$98.2M
Q1 24
$-50.9M
$263.1M
FCF Margin
AGL
AGL
JBHT
JBHT
Q4 25
-1.5%
8.1%
Q3 25
-1.5%
11.5%
Q2 25
-2.7%
6.3%
Q1 25
-2.3%
5.4%
Q4 24
0.9%
3.0%
Q3 24
-0.8%
5.3%
Q2 24
-1.5%
3.4%
Q1 24
-3.2%
8.9%
Capex Intensity
AGL
AGL
JBHT
JBHT
Q4 25
0.2%
4.3%
Q3 25
0.2%
4.4%
Q2 25
0.2%
7.4%
Q1 25
0.3%
8.4%
Q4 24
0.2%
7.1%
Q3 24
0.2%
5.7%
Q2 24
0.2%
9.0%
Q1 24
0.2%
6.9%
Cash Conversion
AGL
AGL
JBHT
JBHT
Q4 25
2.13×
Q3 25
2.85×
Q2 25
3.13×
Q1 25
-2.64×
3.43×
Q4 24
2.04×
Q3 24
2.23×
Q2 24
2.65×
Q1 24
3.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

JBHT
JBHT

JBI$1.5B50%
DCS$842.8M27%
ICS$304.5M10%
FMS$206.3M7%
JBT$200.7M6%

Related Comparisons